Ilization of DNA transposable components from lentiviral vectors. Mob Genet Elem

J Gene Med 2007, 9:403?15. 219. Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, Finegold M, Yant SR, Kay MA, Ologic complications of transfusion therapy in SCD in Nigeria, transmission of Grompe M: In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol Ther 2002, six:759?69. 220. Wilber A, Frandsen JL, Geurts JL, Largaespada DA, Hackett PB, McIvor RS: RNA as a supply of transposase for sleeping beauty-mediated gene insertion and expression in somatic cells and tissues. Mol Ther 2006, 13:625?30. 221. Sharma N, Cai Y, Bak RO, Jakobsen MR, Schroder LD, Mikkelsen JG: Effective sleeping beauty DNA transposition from DNA minicircles. Mol Ther Nucleic Acids 2013, two:e74. 222. Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H, Hackett PB, Kohn DB, Shpall EJ, Champlin RE, Cooper LJ: Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty method. Cancer Res 2008, 68:2961?971. 223. Huang X, Guo H, title= j.jecp.2014.02.009 Kang J, Choi title= 02699931.2015.1049516 S, Zhou TC, Tammana S, Lees CJ, Li ZZ, Milone M, Levine BL, et al: Sleeping Beauty transposon-mediated engineering of human major T cells for therapy of CD19+ lymphoid malignancies. Mol Ther 2008, 16:580?89. 224. Huang X, Wilber A, McIvor RS, Zhou X: DNA transposons for modification of human primary T lymphocytes. Strategies in mol biol 2009, 506:115?26. 225. Jin Z, Maiti S, Huls H, Singh H, Olivares S, Mates L, Izsvak Z, Ivics Z, Lee DA, Champlin RE, Cooper LJ: The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Ther 2011, 18:849?56. 226. Hollis RP, Nightingale SJ, Wang X, Pepper KA, Yu XJ, Barsky L, Crooks GM, Kohn DB: Stable gene transfer to human CD34(+) hematopoietic cells employing the Sleeping Beauty transposon. Exp Hematol 2006, 34:1333?343. 227. Sumiyoshi T, Holt NG, Hollis RP, Ge S, Cannon PM, Crooks GM, Kohn DB: Steady transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon technique. Hum Gene Ther 2009, 20:1607?626. 228. Xue X, Huang X, Nodland SE, Mates L, Ma L, Izsvak Z, Ivics Z, LeBien TW, McIvor RS, Wagner JE, Zhou X: Steady gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon program. Blood 2009, 114:1319?330. 229. Wilber A, Linehan JL, Tian X, Woll PS, Morris JK, Belur LR, McIvor RS, Kaufman DS: Efficient and steady transgene expression in human embryonic stem cells making use of transposon-mediated gene transfer. Stem Cells 2007, 25:2919?927. 230. Orban TI, Apati A, Nemeth A, Varga N, Krizsik V, Schamberger A, Szebenyi K, Erdei Z, Varady G, Karaszi E, et al: Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.Ilization of DNA transposable elements from lentiviral vectors. Mob Genet Elem 2011, 1:139?44. 217. Staunstrup NH, Mikkelsen JG: Integrase-defective lentiviral vectors stage for nonviral integration machineries. Curr Gene Ther 2011, 11:350?62. 218. Aronovich EL, Bell JB, Belur LR, Gunther R, Koniar B, Erickson DC, Schachern PA, Matise I, McIvor RS, Whitley CB, Hackett PB: Prolonged expression of a lysosomal enzyme in mouse liver immediately after Sleeping Beauty transposonmediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses.